CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8632)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 15, 2019 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim IH. Current status of adjuvant chemotherapy for gastric cancer. World J Gastrointest Oncol 2019; 11(9): 679-685 [PMID: 31558973 DOI: 10.4251/wjgo.v11.i9.679] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i9/679.htm |
| Number | Citing Articles |
| 1 |
Xin Zhang, Hejing Huang, Ziran Wei, Zhenxin Zhu, Dejun Yang, Hongbing Fu, Jiapeng Xu, Zunqi Hu, Yu Zhang, Qing You, Xin Huang, Ronglin Yan, Weimin Wang, Qingping Cai. <p>Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis</p>. Cancer Management and Research 2020; : 6641 doi: 10.2147/CMAR.S258360
|
| 2 |
Yuqin Li, Xiaolan Lu, Peiying Tian, Kai Wang, Jianping Shi. Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway. BMC Complementary Medicine and Therapies 2021; 21(1) doi: 10.1186/s12906-021-03225-1
|
| 3 |
Sung E. Oh, Ji Y. An, Min-Gew Choi, Jun H. Lee, Tae S. Sohn, Jae M. Bae. Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211039679
|
| 4 |
Kun Zhuang, Hanqing Guo, Hailing Tang, Yuan Yan, Zhenwei Yang, Yu Wang. Suppression of FAK by nexrutine inhibits gastric cancer progression. Life Sciences 2020; 257: 118100 doi: 10.1016/j.lfs.2020.118100
|
| 5 |
Ting-Yao Wang, Chao-Yu Chen, Tzu-Hao Huang, Yao-Hsu Yang, Ko-Jung Chen, Wen-Chi Chou, Chang-Hsien Lu. Protein-bound polysaccharide K prolonged overall survival in gastric cancer patients from a non-Japanese Asian country who received gastrectomy and adjuvant chemotherapy. Medicine 2022; 101(29): e29632 doi: 10.1097/MD.0000000000029632
|
| 6 |
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence. 2022; : 125 doi: 10.1007/978-3-031-10839-6_5
|
| 7 |
Felipe S. Furtado, Krista E. Suarez-Weiss, Barbara J. Amorim, Jeffrey W. Clark, Maria Picchio, Mukesh Harisinghani, Onofrio Antonio Catalano. Clinical PET/MRI. 2023; : 333 doi: 10.1016/B978-0-323-88537-9.00015-5
|
| 8 |
Kenan İsmayilzade, Erkan Güler, Muhtar Sinan Ersin, Özgür Fırat, Berk Göktepe, Taylan Özgür Sezer. Effect of preoperative C-reactive protein/albumin ratio on postoperative survial in gastric adenocarcinomas. Ege Tıp Dergisi 2024; 63(4): 536 doi: 10.19161/etd.1522823
|
| 9 |
Chih-Chieh Yen, Yan-Shen Shan, Ying-Jui Chao, Ting-Kai Liao, I-Shu Chen, Hsuan-Yi Huang, I-Ting Liu, Chia-Jui Yen. Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08487-z
|
| 10 |
Xiaobei Zhang, Meng Jin, Shiqi Liu, Mingde Zang, Lei Hu, Tao Du, Baogui Zhang. The roles and molecular mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells. Heliyon 2023; 9(4): e14655 doi: 10.1016/j.heliyon.2023.e14655
|
| 11 |
Toshizo Takayama, Yasushi Tsuji. Updated Adjuvant Chemotherapy for Gastric Cancer. Journal of Clinical Medicine 2023; 12(21): 6727 doi: 10.3390/jcm12216727
|
| 12 |
Luca Schiliró Tristão, Wagner José Riva, Clara Lucato dos Santos, Wanderley Marques Bernardo. Omentectomy vs omentum preservation for advanced gastric cancer: A systematic review and meta-analysis. Surgical Oncology 2023; 49: 101963 doi: 10.1016/j.suronc.2023.101963
|
| 13 |
Lili Wu, Ying Feng, Zhijun Wu, Hui Xu, Cheng Zhang, Jie Ning, Rong Wang, Jianqiong Chen, Minmin Xie, Yi Zhang, Lijia Bu, Jiqing Hao, Tai Ma. Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02390-4
|
| 14 |
Anne-Leen Deleu, Machaba Junior Sathekge, Alex Maes, Bart De Spiegeleer, Mike Sathekge, Christophe Van de Wiele. Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review. Biomedicines 2020; 8(9): 304 doi: 10.3390/biomedicines8090304
|
| 15 |
Da-Hyun Kim, Seul Lee, Hyeok Gu Kang, Hyun-Woo Park, Han-Woong Lee, Dongin Kim, Dong-Hoon Yoem, Jin-Hyung Ahn, Eunsin Ha, Weon-Kyoo You, Sang Hoon Lee, Seok-Jun Kim, Kyung-Hee Chun. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer. BMB Reports 2020; 53(10): 533 doi: 10.5483/BMBRep.2020.53.10.103
|
| 16 |
Shahriyar Gholizadeh, Amin Jalili, Fatemeh Mosaffa, Khadijeh Jamialahmadi. Brevinin-2R: Antimicrobial Peptide with Cytotoxic and Apoptogenic Activity Against Daunorubicin Resistant Gastric Cancer Cells. Pharmaceutical Chemistry Journal 2023; 56(12): 1587 doi: 10.1007/s11094-023-02831-2
|
| 17 |
Hannah G. McDonald, Megan M. Harper, Kristen Hill, Anqi Gao, Angelica L. Solomon, Charles J. Bailey, Miranda Lin, Mautin Barry-Hundeyin, Michael J. Cavnar, Samuel H. Mardini, Prakash J. Pandalai, Reema A. Patel, Jill M. Kolesar, Justin A. Rueckert, Lawrence Hookey, Mark Ropeleski, Shaila J. Merchant, Joseph Kim, Mei Gao. Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. Cancers 2023; 15(11): 3036 doi: 10.3390/cancers15113036
|
| 18 |
Sang-Ho Jeong, Rock Bum Kim, Sung Eun Oh, Ji Yeong An, Kyung Won Seo, Jae-Seok Min. Efficacy of S-1 or Capecitabine Plus Oxaliplatin Adjuvant Chemotherapy for Stage II or III Gastric Cancer after Curative Gastrectomy: A Systematic Review and Meta-Analysis. Cancers 2022; 14(16): 3940 doi: 10.3390/cancers14163940
|
| 19 |
Victoria Neumeyer, Anna Brutau-Abia, Michael Allgäuer, Nicole Pfarr, Wilko Weichert, Christina Falkeis-Veits, Elisabeth Kremmer, Michael Vieth, Markus Gerhard, Raquel Mejías-Luque. Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response. Cellular and Molecular Gastroenterology and Hepatology 2021; 11(4): 1071 doi: 10.1016/j.jcmgh.2020.11.005
|
| 20 |
Qingqian Zhang, Yue Qian, Ying Yin. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2021; 77(12): 1791 doi: 10.1007/s00228-021-03187-w
|